Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Amgen Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $42.69B | $41.54B - $44.26B | $19.24B | $27.477 | 13 |
| Dec 2029 | $41.13B | $40.02B - $42.64B | $18.53B | $25.882 | 13 |
| Dec 2028 | $39.76B | $39.74B - $39.78B | $17.92B | $24.367 | 27 |
| Dec 2027 | $38.80B | $37.57B - $39.92B | $17.48B | $23.45 | 25 |
| Dec 2026 | $37.80B | $37.43B - $38.28B | $17.03B | $22.389 | 25 |
| Dec 2025 | $36.36B | $36.16B - $36.77B | $16.38B | $21.318 | 20 |
| Dec 2024 | $33.20B | $33.02B - $33.46B | $14.96B | $19.605 | 20 |
| Dec 2023 | $30.93B | $30.10B - $32.07B | $13.94B | $5.834 | 11 |
| Dec 2022 | $26.17B | $25.45B - $26.93B | $11.94B | $17.681 | 12 |
| Dec 2021 | $26.00B | $25.28B - $26.76B | $10.92B | $16.823 | 9 |
| Dec 2020 | $25.36B | $24.66B - $26.10B | $11.40B | $16.076 | 11 |
| Dec 2019 | $23.19B | $22.54B - $23.86B | $11.94B | $14.599 | 8 |